Brandon Dawson has built companies that move fast and think big. As co-founder of Cardone Ventures alongside Grant Cardone, and of 10X Health System, he sits at an unusual intersection: one part business strategist, one part precision health architect. He’s direct and wastes no time getting to what he sees as the central problem: how most people engage with their health is categorically wrong.
“People are done being passive,” he says. “For decades, the system trained us to show up when something was wrong, when you’re sick, when you’re in pain, when the numbers are bad. That model is collapsing.”
What’s replacing it, Dawson argues, isn’t simply better information. It’s a reckoning with data. The kind that used to sit exclusively inside hospital labs and research institutions is now accessible to anyone willing to look. Genetics, biomarker tracking, and real-time physiological feedback. “That’s not a niche luxury anymore,” he says. “That’s the new baseline expectation for anyone who takes their performance seriously.”
Personalisation versus precision
The word ‘personalised’ gets used loosely in wellness, and Dawson draws a firm line between it and what he’s actually building.
“The industry deserves credit for moving in that direction,” he concedes, “but what most people call ‘personalised health’ is still, in many ways, a more refined version of the same averaging problem. You fill out a lifestyle questionnaire, you get a customised supplement recommendation, maybe you track your steps and your sleep. That’s better than nothing, but it’s not precision.”
Precision, he explains, starts somewhere most wellness programmes don’t go: your DNA.
“Your genetic makeup is not a preference or a lifestyle indicator. It’s the foundational code that determines how your body processes nutrients, manages inflammation, responds to training, and metabolises hormones. It’s fixed, it’s specific, and it’s unique to you.”
At 10X Health, that genetic foundation is layered with live blood biomarker data, over 70 markers covering everything from hormone levels to inflammatory response, and integrated with real-time physiological feedback from wearables.
The result is a protocol that could only belong to one person. “Not because we customised a template, but because every recommendation is a direct response to what your specific biology is telling us across three distinct data streams simultaneously.”
The cellular machinery behind longevity
On longevity, Dawson is clear about what the word actually means to him.
“Longevity isn’t about adding years to your life. It’s about adding life to your years.” The machinery behind that, he explains, is cellular. Mitochondrial health. Metabolic resilience. Things most people have never connected to their day-to-day experience.
“Most people don’t connect their brain fog or afternoon crashes to mitochondrial inefficiency,” he says, “but that’s exactly what’s happening for a huge percentage of the population.” When mitochondria are compromised through nutrient deficiencies, chronic inflammation or poor sleep, every system pays a price. Metabolic resilience follows the same logic: blood sugar regulation and insulin sensitivity are among the strongest predictors of how well a person ages.
“We identify these vulnerabilities before they become conditions,” he says. “The goal isn’t to treat metabolic disease. It’s to ensure it never develops.”
Cutting through the supplement noise
The supplement industry is one of the most crowded, least regulated spaces in consumer health. Dawson doesn’t soften his assessment. “Our industry has earned the skepticism,” he says. “There is an enormous amount of noise, influencer-driven supplement stacks, detox protocols with zero clinical backing, marketing that exploits people’s desire to feel better.”
His advice is straightforward: demand data. Not anecdotes, not endorsements, but specific data. What deficiency does this product address? What does your bloodwork show? What genetic markers support this recommendation?
But even when the need is real, ingredient quality is where most companies quietly cut corners. He uses vitamin B12 as his example. “The majority of supplements use a synthetic form called cyanocobalamin. It’s cheap, it’s stable, and it technically raises your B12 levels on a lab test.” The issue is that cyanocobalamin isn’t found naturally in the human body and requires conversion before it can be used. Methylcobalamin, by contrast, is already in a bioactive state. “Research has shown it remains in the body for a longer period and at higher levels,” he says. “That’s not a marginal difference. That’s the gap between a supplement that performs and one that merely appears to.”
Every ingredient in 10X’s product line is reviewed by medical advisors for the form, source, and delivery mechanism, not just whether the active compound is present. “The question we ask isn’t just whether an ingredient works in theory. It’s whether the specific form gives your body the best possible chance to actually use it.”
Beyond the clinic
The traditional clinic, Dawson says, was never the ideal mechanism for wellness. It was simply the only option available.
“Think about what’s already possible,” he says. “You can collect a DNA sample at home and have a comprehensive genetic profile within days. Wearables give you continuous data on heart rate variability, sleep quality, blood oxygen. Blood panels are moving toward at-home collection. AI platforms are beginning to interpret this data in real time.”
Genetics provide your baseline blueprint; bloodwork shows where that blueprint is being undermined by environment and choices; wearables provide the continuous feedback loop that tells you whether your interventions are working. “When those three data streams are integrated, the traditional clinic becomes one node in a much larger ecosystem, not the centre of it.”
He’s careful not to frame this as the end of clinical medicine. “The future isn’t clinic versus consumer technology. It’s both, working in an intelligent, connected system.”
10X Health System currently delivers this across 46 countries, operating precision IV therapy through certified medical facilities and building out a wider suite of services that includes gut health testing, hormone therapy support, and the Superhuman Protocol, a three-stage process combining PEMF therapy, oxygen therapy, and red light therapy designed to support cellular regeneration and recovery.
The next decade: personalisation, AI and the Gulf
On the decade ahead, Dawson identifies three forces he believes will define the next era of wellness: personalisation at scale, AI-powered decision-making, and the globalisation of preventative longevity medicine.
“Imagine a system that knows your genetic predispositions, monitors your real-time biomarkers, tracks your sleep and recovery from wearables, and uses all of that to help you make micro-decisions throughout your day, which foods support your hormonal balance, which type of training matches your recovery capacity right now, when to push and when to restore. That’s not science fiction. That’s where we’re heading.”
On geography, he’s equally direct. “I’m particularly energised by what’s happening in regions like the Gulf. Leaders here are not waiting for the future of healthcare to arrive. They’re building it.” The investment in infrastructure and the ambition around longevity medicine in Abu Dhabi and across the UAE, he says, is genuinely world-class. “This region is going to be central to how precision longevity medicine scales globally over the next decade.”
The Cardone blueprint, and what business taught him about health
What building Cardone Ventures alongside Grant Cardone taught him about scale and conviction turns out to be inseparable from how he thinks about health optimisation.
“Grant operates at a level of conviction and intensity that forces you to remove your own ceiling,” he says. “The biggest thing I took from building together is that your limitation is rarely the market. It’s the size of your thinking.” Speed and commitment followed as practical lessons. “Most businesses fail not because the idea was wrong but because the execution was too tentative.”
The deeper carry-over is structural. In business, you start by understanding your baseline, where you are financially, operationally, and culturally. You identify the gaps between that baseline and where you want to go, build precise and measurable interventions to close them, and track the data to know whether your strategy is working. “You don’t guess. You don’t hope. You measure, adjust, and scale what works.”
That, he says, is exactly how 10X Health approaches optimisation. “Your genetics are your baseline blueprint. Your blood work identifies the gaps, the deficiencies, imbalances, and vulnerabilities that are limiting your performance. Your precision protocol is the intervention strategy. And your ongoing testing and wearable data are your performance metrics. The feedback loop is the same.”
What he’s observed consistently across both domains is one shared characteristic among the highest performers. “They’re ruthlessly honest about where they are. They don’t rationalise the bad numbers. They face them, they address them, and they use them as a starting point. Whether it’s a P&L or a blood panel, the willingness to look at the truth without flinching is the foundation of every meaningful result I’ve ever seen.”
The importance of building community around a vision, of making people feel part of something larger than a transaction, is something he has carried from Cardone Ventures directly into 10X Health. “We’re not just selling a product or a test. We’re inviting people into a fundamentally different relationship with their own health. The mission has to be bigger than the business.”
Read: Staying calm in uncertain times: Here’s what UAE mental health professionals advise
